Anhui Anke Biotechnology (Group) Co Ltd Class A 300009
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 9.55
- Day Range
- CNY 9.51–9.97
- 52-Week Range
- CNY 7.56–11.56
- Bid/Ask
- CNY 9.85 / CNY 9.86
- Market Cap
- CNY 16.52 Bil
- Volume/Avg
- 22.0 Mil / 16.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.14
- Price/Sales
- 5.54
- Dividend Yield (Trailing)
- 2.53%
- Dividend Yield (Forward)
- 2.53%
- Total Yield
- 2.62%
Company Profile
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,986
- Website
- http://www.ankebio.com
Comparables
Valuation
|
Metric
|
300009
|
603590
|
688197
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.14 | 26.55 | — |
Price/Book Value | 4.28 | 1.49 | 7.02 |
Price/Sales | 5.54 | 4.55 | 1,486.96 |
Price/Cash Flow | 14.66 | 33.81 | — |
Price/Earnings
300009
603590
688197
Financial Strength
|
Metric
|
300009
|
603590
|
688197
|
|---|---|---|---|
Quick Ratio | — | 3.91 | 7.97 |
Current Ratio | — | 5.07 | 11.32 |
Interest Coverage | — | 119.04 | −981.69 |
Quick Ratio
300009
603590
688197
Profitability
|
Metric
|
300009
|
603590
|
688197
|
|---|---|---|---|
Return on Assets (Normalized) | — | 4.79% | −27.12% |
Return on Equity (Normalized) | — | 5.68% | −29.24% |
Return on Invested Capital (Normalized) | — | 4.55% | −30.62% |
Return on Assets
300009
603590
688197
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Cnhbjjmvxr | Dycmv | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Gyrfzhjk | Ncmzcq | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Vssvzjk | Ctzjbsh | $99.5 Bil | |
MRNA
| Moderna Inc | Lvqppqh | Hkdz | $38.8 Bil | |
ARGX
| argenx SE ADR | Mzmthtvn | Vbgl | $21.4 Bil | |
BNTX
| BioNTech SE ADR | Qsphryh | Jrbcd | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Rqwyhlgh | Zhvcpq | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bypbrhs | Gxwjt | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Hlccjhnk | Kkqdvp | $12.5 Bil | |
INCY
| Incyte Corp | Hzznhfnsd | Qxtdyds | $11.6 Bil |